Molecular features differences between patients with BRAF mutant melanoma and thyroid cancer.
Yingying Huang(Nanfang Hospital), Ledu Zhou(Central South University), Yunbo Zhao(University of Science and Technology of China), Ke Ye(Sun Yat-sen University), Xuefeng Xia(BGI Group (China)), Tongdi Fang(Central South University), Guo Long(Central South University), Mingming Yuan
Cited by 0
Related Papers
The protective role of selenium on the toxicity of cisplatin-contained chemotherapy regimen in cancer patients
|Biological Trace Element Research|1997|122
Extracellular vesicles derived from <i>Akkermansia muciniphila</i> promote placentation and mitigate preeclampsia in a mouse model
|Journal of Extracellular Vesicles|2023|69
Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial
|The Lancet. Gastroenterology & hepatology|2025|45